REGN vs ZONE · P/E 14, rev $14.34B vs rev $2.1M
Regeneron Pharmaceuticals Inc (REGN) versus CleanCore Solutions Inc. (ZONE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
CleanCore Solutions Inc. (ZONE) is a pollution & treatment controls company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported ZONE revenue for 2025-06-30 was $2.1M. Net income was -$6.7M. Revenue was up 29.2% from 2024-06-30 to 2025-06-30. ZONE currently screens at market cap $28.9M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. ZONE currently screens at market cap $28.9M.
Not investment advice. Open the REGN and ZONE stock pages for the full models.
Not investment advice.